Neurocrine

+$0.17 (+0.17%) As of 4:22 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders.

CEO
Kevin Charles Gorman
Employees
845
Headquarters
San Diego, California
Founded
1992

NBIX Key Statistics

Market Cap
9.72B
Price-Earnings Ratio
27.55
Dividend Yield
—
Average Volume
584.70K
High Today
$103.58
Low Today
$102.14
Open Price
$103.04
Volume
143.33K
52 Week High
$120.27
52 Week Low
$84.77

NBIX News

Simply Wall St2h

Does Neurocrine Biosciences Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankrupt
Simply Wall StOct 23

Is Neurocrine Biosciences, Inc.'s Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Most readers would already be aware that Neurocrine Biosciences' (NASDAQ:NBIX) stock increased significantly by 9.8% over the past month. Given the company's im

NBIX Earnings

$0.00
$0.47
$0.95
$1.42
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
$0.60 per share
Actual
Available Nov 1, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure